Literature DB >> 9760198

A high proportion of mutations in the BRCA1 gene in German breast/ovarian cancer families with clustering of mutations in the 3' third of the gene.

J Dong1, J Chang-Claude, Y Wu, V Schumacher, I Debatin, P Tonin, B Royer-Pokora.   

Abstract

We have analyzed 61 German breast and breast/ovarian cancer families for BRCA1 mutations using single-strand conformation polymorphism analysis (SSCP) followed by sequencing. Forty-seven of the families had at least three cases (at least two under 60 years) and 14 families had only two cases of breast/ovarian cancer (at least one under 50 years). Twenty-eight families were breast/ovarian and 33 were breast cancer-only families. Eighteen mutations in BRCA1 were detected in 11/28 breast/ovarian cancer families and 7/33 breast cancer families and none in the families with only two cases. We identified 17 truncation mutations (8 frameshift, 7 nonsense and 2 splice variants) and one missense mutation. Seven of these are novel and two, the 5382insC and 5622C-->T mutations, occurred in two apparently unrelated families. The genotype of the two families with the 5382insC mutation is compatible with the rare haplotype segregating with the 5382insC mutation in different populations, further supporting its European origin. One unclassified missense alteration, R841W, was found in one family but did not segregate with the disease, suggesting that it is more likely a polymorphism. We also report and discuss the sequence of several new unclassified single-nucleotide changes first identified by SSCP. Of the 18 mutations, 13 occurred in the 3' third of the gene (end of exon 11-24) and ovarian cancers were found in eight of these families.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9760198     DOI: 10.1007/s004390050799

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  5 in total

1.  BRCA1 testing in breast and/or ovarian cancer families from northeastern France identifies two common mutations with a founder effect.

Authors:  Danièle Muller; Catherine Bonaiti-Pellié; Joseph Abecassis; Dominique Stoppa-Lyonnet; Jean-Pierre Fricker
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

2.  Degradation of BRCA2 in alkyltransferase-mediated DNA repair and its clinical implications.

Authors:  Subha Philip; Srividya Swaminathan; Sergey G Kuznetsov; Sreenivas Kanugula; Kajal Biswas; Suhwan Chang; Natalia A Loktionova; Diana C Haines; Philipp Kaldis; Anthony E Pegg; Shyam K Sharan
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

3.  Understanding missense mutations in the BRCA1 gene: an evolutionary approach.

Authors:  Melissa A Fleming; John D Potter; Christina J Ramirez; Gary K Ostrander; Elaine A Ostrander
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-16       Impact factor: 11.205

4.  Analysis of 30 putative BRCA1 splicing mutations in hereditary breast and ovarian cancer families identifies exonic splice site mutations that escape in silico prediction.

Authors:  Barbara Wappenschmidt; Alexandra A Becker; Jan Hauke; Ute Weber; Stefanie Engert; Juliane Köhler; Karin Kast; Norbert Arnold; Kerstin Rhiem; Eric Hahnen; Alfons Meindl; Rita K Schmutzler
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

5.  BRCA1/2 Mutations in Vietnamese Patients with Hereditary Breast and Ovarian Cancer Syndrome.

Authors:  Trong-Nhan N Le; Van-Khanh Tran; Thu-Thuy Nguyen; Nam S Vo; Tham H Hoang; Hoang-Long Vo; Thanh-Hai T Nguyen; Phuoc-Dung Nguyen; Viet-Tien Nguyen; Thanh-Van Ta; Huy-Thinh Tran
Journal:  Genes (Basel)       Date:  2022-01-29       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.